Sareum (LON:SAR) Stock Price Passes Above 50 Day Moving Average – Here’s Why

Sareum Holdings plc (LON:SAR)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 17.90 and traded as high as GBX 22. Sareum shares last traded at GBX 20, with a volume of 28,846 shares changing hands.

Sareum Price Performance

The firm has a 50 day moving average price of GBX 17.90 and a two-hundred day moving average price of GBX 16.56. The company has a market capitalization of £27.61 million, a price-to-earnings ratio of -5.13 and a beta of -1.08.

Sareum (LON:SAR) last announced its earnings results on Thursday, March 12th. The company reported GBX (1.20) earnings per share for the quarter. Analysts predict that Sareum Holdings plc will post -3.8 earnings per share for the current year.

About Sareum

Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.
Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).
Sareum also has an economic interest in SRA737, a clinical-stage oral, selective Checkpoint kinase 1 (Chk1) inhibitor that targets cancer cell replication and DNA damage repair mechanisms.